XLHealth, a Baltimore-based provider of health plan solutions for Medicare beneficiaries with special needs, announced the enrollment of its 100,000th member, and it sees room for more growth despite expected Medicare Advantage cuts
XLHealth, a Baltimore-based provider of health plan solutions for Medicare beneficiaries with special needs, announced the enrollment of its 100,000th member, and it sees room for more growth despite expected Medicare Advantage cuts.
“There is going to be increasing downward price cut pressure on all plans,” says Paul Serini, executive vice president, XLHealth. “As a starting point we’ll have that same pressure. That said, most of healthcare reform is aligned with special need plans like ours.”
He says in the next two to four years, he sees tremendous opportunities for special needs plans.
“When the dust settles from healthcare reform, any MAPD (Medicare Advantage Prescription Drug) company serving a population that’s complex enough can do a better job than traditional services,” he says. “We know we can deliver better value to our members and the Medicare system for the chronically ill.”
XLHealth focuses on a largely rural, medically underserved market and targets older members. Care Improvement Plus' chronic condition special needs plan combines medical coverage - hospital and doctors' visits - with tailored Medicare Part D prescription drug coverage and care management support for Medicare beneficiaries with diabetes and heart failure.
Care Improvement Plus launched in 2006 and now serves seniors in Arkansas, Georgia, Missouri, South Carolina, Texas and 11 Maryland counties. XLHealth estimates that approximately 7 million Medicare beneficiaries across all six states are eligible to enroll in a Care Improvement Plus plan and benefit from its model of care.
Serini says the company plans to expand in 2012. It has a target list of seven more states and 170 counties.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
A Motor Neuron Mystery Points to New Potential SMA Treatment Targets
December 20th 2024Some muscles are resistant to the loss of motor neurons seen in patients with spinal muscular atrophy, and new research has discovered that even in muscles that appeared resistant to SMA, subtle changes had occurred at the cellular level.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen